Product Introduction:
Capnea 20 mg Oral Solution contains Caffeine Citrate, a central nervous system stimulant. It is used to treat apnea of prematurity, a condition in premature infants where breathing repeatedly stops for short periods due to immature respiratory control.
Uses:
-
Treatment of apnea of prematurity in neonates
-
Improves breathing in premature infants
-
Enhances respiratory drive
Benefits:
-
Stimulates breathing and reduces apnea episodes
-
Supports better oxygenation
-
Reduces need for mechanical ventilation in neonates
-
Promotes neurological development by maintaining proper oxygen supply
Composition:
-
Caffeine Citrate – 20 mg/2 ml
Side Effects:
-
Feeding intolerance
-
Irritability or restlessness
-
Increased heart rate
-
Abdominal bloating
-
Rare: seizures or abnormal heart rhythms
Safety Advice:
-
To be used under strict medical supervision in neonatal care
-
Monitor heart rate, breathing, and serum levels during use
-
Dose adjustments may be needed in kidney or liver dysfunction
-
Store below 25°C and protect from light
-
Shake well before use and follow precise dosing